A. C. Muntau Et Al. , "Effects of oral sepiapterin on blood Phe concentration in a broad range of patients with phenylketonuria (APHENITY): results of an international, phase 3, randomised, double-blind, placebo-controlled trial.," Lancet (London, England) , vol.404, no.10460, pp.1333-1345, 2024
Muntau, A. C. Et Al. 2024. Effects of oral sepiapterin on blood Phe concentration in a broad range of patients with phenylketonuria (APHENITY): results of an international, phase 3, randomised, double-blind, placebo-controlled trial.. Lancet (London, England) , vol.404, no.10460 , 1333-1345.
Muntau, A. C., Longo, N., Ezgu, F., Schwartz, I. V. D., Lah, M., Bratkovic, D., ... Margvelashvili, L.(2024). Effects of oral sepiapterin on blood Phe concentration in a broad range of patients with phenylketonuria (APHENITY): results of an international, phase 3, randomised, double-blind, placebo-controlled trial.. Lancet (London, England) , vol.404, no.10460, 1333-1345.
Muntau, Ania Et Al. "Effects of oral sepiapterin on blood Phe concentration in a broad range of patients with phenylketonuria (APHENITY): results of an international, phase 3, randomised, double-blind, placebo-controlled trial.," Lancet (London, England) , vol.404, no.10460, 1333-1345, 2024
Muntau, Ania C. Et Al. "Effects of oral sepiapterin on blood Phe concentration in a broad range of patients with phenylketonuria (APHENITY): results of an international, phase 3, randomised, double-blind, placebo-controlled trial.." Lancet (London, England) , vol.404, no.10460, pp.1333-1345, 2024
Muntau, A. C. Et Al. (2024) . "Effects of oral sepiapterin on blood Phe concentration in a broad range of patients with phenylketonuria (APHENITY): results of an international, phase 3, randomised, double-blind, placebo-controlled trial.." Lancet (London, England) , vol.404, no.10460, pp.1333-1345.
@article{article, author={Ania C Muntau Et Al. }, title={Effects of oral sepiapterin on blood Phe concentration in a broad range of patients with phenylketonuria (APHENITY): results of an international, phase 3, randomised, double-blind, placebo-controlled trial.}, journal={Lancet (London, England)}, year=2024, pages={1333-1345} }